ArticleStem cells and development2017

Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia.

Anna Chorzalska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.